These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18035515)

  • 1. [Factors to consider in managing drug interactions in clinical practice].
    Charpiat B; Allenet B; Roubille R; Escofier L; Bedouch P; Juste M; Rose FX; Conort O
    Presse Med; 2008 Apr; 37(4 Pt 2):654-64. PubMed ID: 18035515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of four drug interaction compendia.
    Vitry AI
    Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs.
    Chao SD; Maibach HI
    Am J Clin Dermatol; 2005; 6(2):105-11. PubMed ID: 15799682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Always vigilant. At Banner Health in Phoenix, a computerized decision-support system helps warn caregivers when adverse drug interactions or other harmful events are imminent.
    Morrissey J
    Mod Healthc; 2003 May; 33(21):28-30, 35. PubMed ID: 12800290
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions.
    Magro L; Moretti U; Leone R
    Expert Opin Drug Saf; 2012 Jan; 11(1):83-94. PubMed ID: 22022824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues of decision support in institutional pharmacy systems.
    Mackowiak LR; Hayward SL
    Pharm Pract Manag Q; 1998 Apr; 18(1):35-45. PubMed ID: 10177541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports.
    Aronson JK
    Expert Rev Clin Pharmacol; 2015; 8(4):399-409. PubMed ID: 26018632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing exacerbation of an ADE with automated decision support.
    Galanter WL; DiDomenico RJ; Polikaitis A
    J Healthc Inf Manag; 2002; 16(4):44-9. PubMed ID: 12365299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods used by pharmacy departments to identify drug interactions.
    Elanjian S; Gora ML; Symes LR
    Am J Hosp Pharm; 1993 Dec; 50(12):2546-9. PubMed ID: 8122690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Even in best-run centers, preventable medication errors lengthen LOS, increase costs.
    Health Care Cost Reengineering Rep; 1998 Oct; 3(10):149-51. PubMed ID: 10186033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interactions and adverse drug reactions: how to obtain information].
    Fattinger KE
    Praxis (Bern 1994); 1999 Apr; 88(16):713-8. PubMed ID: 10355337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.
    Hines LE; Saverno KR; Warholak TL; Taylor A; Grizzle AJ; Murphy JE; Malone DC
    Res Social Adm Pharm; 2011 Dec; 7(4):359-68. PubMed ID: 21530417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the pharmacy department in the prevention of adverse drug events: a survey of current practices.
    Lin B; Anderson LR
    Pharm Pract Manag Q; 1997 Apr; 17(1):10-6. PubMed ID: 10166240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical-pharmacological counseling in Odense, 1997-2003].
    Hedegaard U; Damkier P
    Ugeskr Laeger; 2004 Nov; 166(45):4030-2. PubMed ID: 15565960
    [No Abstract]   [Full Text] [Related]  

  • 16. Contradictions in contraindications for drug-drug interactions.
    Shah VS; Weber RJ; Nahata MC
    Ann Pharmacother; 2011 Mar; 45(3):409-11. PubMed ID: 21386019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions to radiopharmaceuticals: the RSNA-SNM-USP Drug Product Problem Reporting Program.
    Silberstein EB
    Radiology; 1997 Aug; 204(2):34A. PubMed ID: 9240510
    [No Abstract]   [Full Text] [Related]  

  • 18. A measured dose of safety. Addressing adverse drug events is among first steps prescribed as Trinity health installs an electronic medical record system.
    Gardner E
    Mod Healthc; 2003 Feb; 33(8):32, 34, 36. PubMed ID: 12632860
    [No Abstract]   [Full Text] [Related]  

  • 19. Capability of hospital computer systems in performing drug-use evaluations and adverse drug event monitoring.
    Grasela TH; Walawander CA; Kennedy DL; Jolson HM
    Am J Hosp Pharm; 1993 Sep; 50(9):1889-95. PubMed ID: 8135235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contextualization of automatic alerts during electronic prescription: researchers' and users' opinions on useful context factors.
    Ammenwerth E; Hackl WO; Riedmann D; Jung M
    Stud Health Technol Inform; 2011; 169():920-4. PubMed ID: 21893880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.